Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 27 June 1997:
Vol. 276. no. 5321, p. 1962
DOI: 10.1126/science.276.5321.1962
Prev | Table of Contents | Next

News & Comment

GENOMICS:
Alzheimer's Maverick Moves to Industry

Eliot Marshall

Since 1994, the British drug company Glaxo Wellcome has been buying bits and pieces of U.S. biotech firms as part of a push into genetics. On 17 June, the company announced a surprising choice to direct its $47 million genetics empire: Allen Roses of Duke University, a prominent neuroscientist and controversial Alzheimer's disease researcher.

Read the Full Text

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)